Novum Therapeutics
Novum's digital/mobile health device is a novel, disruptive, non-invasive and comfortable alternative to CPAP for the effective treatment of sleep apnea.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location Minneapolis, MN, USA
- Currency USD
- Website NovumThera.com
Company Summary
Sleep apnea afflicts over 100 million people and the most common yet highly disliked treatment is a CPAP mask. Novum has developed a very small non-invasive therapy device which uses clinically proven neuromodulation technology to treat apnea events only as they occur. Untreated sleep apnea may cause cardiovascular diseases, stroke, diabetes and other severe comorbidities. It is estimated only 10% of apnea sufferers actively treat their disease.
Team
-
President & CEO24 year medical device development & leadership career primarily in emerging and rapid growth companies.
President & COO of Dymedix Corp, COO of Meier Technologies, VP of Operations of Synovis Surgical Innovations, Dir. of Mfg & Operations at LecTec Corp., Engineering Mgr at Orthomet Inc., and financial project management for Honeywell.
BA in Business from Hamline University and a MS in Manufacturing Systems from the University of St. Thomas.
-
Daniel L. Mooradian, PhDDirector of TechnologyPresident of The Simpatico Group; CSO for Innova Medical Design; VP of R&D for Synovis Surgical Innovations; Director of Research & Technology Center for Boston Scientific; VP of R&D for Questar Medical; Asst Professor Laboratory Medicine & Biomedical Engineering at the University of MN.
BS in Biological Sciences from the University of MI, Ph.D. in Experimental Pathology from Wayne State University, Post-doctoral Fellow at the University of MN
-
Ronald M. NelsonChief Financial OfficerOver 30 years broad financial management experience. 10 years in a “big eight” CPA firm. CFO at CHF Solutions; Controller at IntraTherpeutics; with Medical Innovative Partners (seed-stage VC firm) served as CFO for the following portfolio startups: Integ, eMed, Cardia Catheter, Iotek, Larex, and Tacora. Also CFO for Mirror Technologies, and as Treasurer & Controller for Arden Medical.
BA in Business from Gustavus Adolphus College; CPA -1975
-
Marcus J. MianulliDirector of Clinical AffairsPrincipal of Gnarus Medical Consulting; Dir. Research & Business Development for Medtronic; Technical Dir. University of MN Hospital and Sr. Scientist in the Dept of Medicine, Cardiology.
BA and BS in Applied Physiology from Penn State University, Doctoral and Masters Programs in Applied and Cardiovascular Physiology from the University of MN, completed the Executive Business Education Program at the Wharton School, University of Pennsylvania.
-
President & CEO
Advisors
-
Jeffrey C. Robbins, Messerli & Kramer P.A.LawyerUnconfirmed
Timothy J. Smith CPA, KDVAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.